Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Matthew Schlumbrecht, MD
University of Miami
Principal Investigator - Sophia HL George, PhD
University of Miami
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ahmadu Bello University Teaching Hospital (abuth)
Zaria, Kaduna State, Nigeria
Ahmed Umdagas Hamidu, MBBS, FWACSRecruiting
- Broward Health
Fort Lauderdale, Florida, United States
Scott Jordan, MDRecruiting - University of Florida Jacksonville
Jacksonville, Florida, United States
Karina E Hew, MDRecruiting - University of Miami
Miami, Florida, United States
Matthew Schlumbrecht, MD, MPHSophia HL George, PhDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Jun 2026
- Primary completion
- 8 Jun 2029
- Completion
- 8 Jun 2031
- Last update posted
- 23 Jun 2026
- Registered enrollment
- 70
- Registry id
- NCT06412120
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.